Anti-GHDC/ D11LGP1/ LGP1 functional antibody

Anti-GHDC/ D11LGP1/ LGP1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GHDC/GHDC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1584-Ab-1/ GM-Tg-hg-SE1584-Ab-2Anti-Human GHDC monoclonal antibodyHuman
GM-Tg-rg-SE1584-Ab-1/ GM-Tg-rg-SE1584-Ab-2Anti-Rat GHDC monoclonal antibodyRat
GM-Tg-mg-SE1584-Ab-1/ GM-Tg-mg-SE1584-Ab-2Anti-Mouse GHDC monoclonal antibodyMouse
GM-Tg-cynog-SE1584-Ab-1/ GM-Tg-cynog-SE1584-Ab-2Anti-Cynomolgus/ Rhesus macaque GHDC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1584-Ab-1/ GM-Tg-felg-SE1584-Ab-2Anti-Feline GHDC monoclonal antibodyFeline
GM-Tg-cang-SE1584-Ab-1/ GM-Tg-cang-SE1584-Ab-2Anti-Canine GHDC monoclonal antibodyCanine
GM-Tg-bovg-SE1584-Ab-1/ GM-Tg-bovg-SE1584-Ab-2Anti-Bovine GHDC monoclonal antibodyBovine
GM-Tg-equg-SE1584-Ab-1/ GM-Tg-equg-SE1584-Ab-2Anti-Equine GHDC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1584-Ab-1/ GM-Tg-hg-SE1584-Ab-2; GM-Tg-rg-SE1584-Ab-1/ GM-Tg-rg-SE1584-Ab-2;
GM-Tg-mg-SE1584-Ab-1/ GM-Tg-mg-SE1584-Ab-2; GM-Tg-cynog-SE1584-Ab-1/ GM-Tg-cynog-SE1584-Ab-2;
GM-Tg-felg-SE1584-Ab-1/ GM-Tg-felg-SE1584-Ab-2; GM-Tg-cang-SE1584-Ab-1/ GM-Tg-cang-SE1584-Ab-2;
GM-Tg-bovg-SE1584-Ab-1/ GM-Tg-bovg-SE1584-Ab-2; GM-Tg-equg-SE1584-Ab-1/ GM-Tg-equg-SE1584-Ab-2
Products NameAnti-GHDC monoclonal antibody
Target NameGHDC
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-GHDC benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1584-Ag-1Recombinant multi-species GHDC/ D11LGP1/ LGP1 protein

    Target information

    Target IDGM-SE1584
    Target NameGHDC
    Gene ID84514,80860,303542,709656,607630,101095451,515225,100066203
    Gene Symbol and SynonymsD11LGP1,D11Lgp1e,GHDC,LGP1,RGD1308881
    Uniprot AccessionQ8N2G8
    Uniprot Entry NameGHDC_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Gene EnsemblENSG00000167925
    Target ClassificationN/A

    The target: GHDC, gene name: GHDC, also named as D11LGP1, LGP1. Predicted to enable acid-amino acid ligase activity. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.